UNIVERSITE DE MONTPELLIER 1
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Nov 14, 2017 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 101 Total Citation Count
- Mar 28, 2003 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2011/0038,844 COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITIONApr 08, 09Feb 17, 11[A61K, C12N, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9783541 5′-nucleotidase inhibitors and therapeutic uses thereofSep 29, 14Oct 10, 17[A61K, A01N, C07F, C07D]
9687552 Association of poly(N-acryloylglycinamide) with at least one active principleFeb 26, 13Jun 27, 17[A61J, A61K]
9481863 Methods for determining developmental stage of human cumulus cellsJun 29, 12Nov 01, 16[C12Q, C12N]
9453259 Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulationOct 22, 12Sep 27, 16[C12Q]
9358324 Hydrophobic polymer for producing medical devices visible in MRIJul 07, 10Jun 07, 16[A61K, C08G, C08F, A61L]
9260748 Methods for assessing endometrium receptivity of a patientMay 27, 11Feb 16, 16[C12Q, A61B, C40B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0201,128 METHODS FOR SELECTING COMPETENT OOCYTES AND COMPETENT EMBRYOS WITH HIGH POTENTIAL FOR PREGNANCY OUTCOMEAbandonedJul 24, 15Jul 14, 16[C12Q]
2013/0231,263 METHODS FOR SELECTING COMPETENT OOCYTES AND COMPETENT EMBRYOS WITH HIGH POTENTIAL FOR PREGNANCY OUTCOMEAbandonedOct 18, 11Sep 05, 13[C12Q]
2012/0100,117 METHOD FOR CHONDROGENIC DIFFERENTIATION OF PLURIPOTENT OR MULTIPOTENT STEM CELLS USING WNT6AbandonedApr 24, 09Apr 26, 12[A61K, C12N, A61P]
2011/0256,090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications ThereofAbandonedDec 18, 09Oct 20, 11[A61K, C07H, C12Q, C12N, A61P, C40B]
2010/0240,084 USE OF THE PROTIEN MABA (FABG1) OF MYCOBACTERIUM TUBERCULOSIS FOR DESIGNING AND SCREENING ANTIBIOTICSAbandonedApr 14, 09Sep 23, 10[C07H, C12Q, C12N]
2010/0209,426 INHIBITORS OF PROGASTRIN-INDUCED REPRESSION OF ICAT FOR TREATING AND/OR PREVENTING COLORECTAL CANCER, ADENOMATOUS POLYPOSIS OR METASTASIS DISPLAYING PROGASTRIN-SECRETING CELLS AND CELLS IN WHICH THE BETA-CATENIN/TCF-MEDIATED TRANSCRIPTIONAL PATHWAY IS CONSTITUTIVELY ACTIVEAbandonedMay 21, 07Aug 19, 10[A61K, C07H, C12Q, A61P, C07K]
2009/0291,116 Biocompatible and Biodegradable Porous Matrix in Particular Useful for Tissue ReconstructionAbandonedOct 10, 06Nov 26, 09[C08J, A61K, C12Q, C12N, A61L]
2006/0035,294 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibioticsAbandonedMar 28, 03Feb 16, 06[C12N, G01N, G06F, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
